Skip to nav Skip to content

89 article(s) found

Celebrating 40 Years of Advancing Cancer Care

A look back at the advances that have shaped cancer care at Moffitt and beyond

Photo of Dr. Fred Locke on stage at the podium at Cell Coast 2026

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

Cancer Survivor Paddles Missouri River With His Dog

Frank Carter and Amos completed a 64-day canoe trip after beating mantle cell lymphoma

3d rendering of antibodies attacking a cancer cell

What Are Bispecifics and How Do They Help Patients With Cancer?

A new class of immunotherapy is giving doctors another way to guide the immune system toward hard to treat cancers

Moffitt Continues Studying CAR T To Treat Ovarian Cancer

Targeting specific hormone receptor found on cancer cells may be key to success

Immunotherapy Pioneer Steven Rosenberg Reflects on Past Breakthroughs and Future Promise

Legendary researcher connects immunotherapy’s origins to its future at Moffitt

image of women in hospital bed being comforted by another

Many Lymphoma Patients Missing Out on Best Care

Study shows survival drops when CAR T therapy is not offered to eligible patients

A vial of blood identified as from a Multiple Myeloma patient

Identifying Patients at Risk of Multiple Myeloma Relapse Can Improve Treatment Plans

Moffitt researchers lead national effort to refine risk-stratification tools to improve patient outcomes

Ciara Freeman, MD, PhD, specializes in treating people with multiple myeloma, a blood cancer that starts in plasma cells in the bone marrow.

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions